x
African Health Sciences
[contact-form-7 id="2459" title="Sidebar Form"]

  • 256(41)530021
  • info@africanhealthsciences.org
African Health Sciences
  • info@africanhealthsciences.org
  • Give Feedback
  • Home
  • About Us
  • Staff
  • Focus & Scope
  • For Authors
  • More Links
    • About The Journal
    • Latest Articles
    • Journal Archives
    • Our Events
    • Faq’s
  • Contact Us
Logo

Contact Info

  • P. O. Box 7072 Kampala, Uganda
  • +256(41)530021
  • info@africanhealthsciences.org
  • ISSN 1680-6905
  • <!--
  • -->

04Oct2017

Prevalence of intermittent preventive treatment

by admin,  0 Comments

Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana

Verner N Orish, Onyekachi S Onyeabor, Johnson N Boampong, Richmond Afoakwah, Ekene Nwaefuna, Samuel Acquah, Adekunle O Sanyaolu, Nnaemeka C Iriemenam

Abstract

Background: Intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) has been adopted as policy by most countries in sub-Saharan Africa. This cross-sectional study assessed the prevalence of IPTp-SP usage for prevention of malaria among pregnant women as well as evaluated factors associated with IPTp-SP use during pregnancy in Sekondi-Takoradi region of Ghana.

Methods: Pregnant women attending their antenatal-care with either clinical/ultrasound evidence of pregnancy were recruited. Venous blood was screened for malaria using RAPID response antibody kit and Giemsa staining. Haemoglobin estimations were done by cyanmethemoglobin method while Human Immunodeficiency Virus (HIV) screening was performed by the national diagnostic algorithm of two rapid antibody test and western blot confirmation.

Results: Of the 754 consented pregnant women interviewed in this study, 57.8% had received IPTp-SP while 42.2% had not at their first contact with the study personnel. Furthermore, 18.6% (81/436) of those that received IPTp-SP were malaria positive while 81.4% (355/436) were malaria negative. The results also indicated that 47.7% (51/107) of the pregnant women in their third trimester who were meant to have received at least two-doses of SP had received ≥2 doses while 35.5% (38/107) had received 1 dose. In multivariable logistic regression analysis, pregnant women in their third trimester who received ≥2 doses of SP showed decreased likelihoods of malaria (adjusted OR, 0.042; 95% CI, 0.003-0.51; P = 0.013).

Conclusion: IPTp-SP usage among pregnant women in Sekondi-Takoradi reduces malaria and its use for malaria prevention should be strengthened with proper dosage completion and coverage.

Keywords: Malaria in pregnancy, IPTp-SP, anaemia, Ghana

 

Related posts:

The protective effects of aqueous extract of Carica papaya seeds in paracetamol induced nephrotoxici...

Factors influencing the usage of different types of malaria prevention methods during pregnancy in K...

Idiopathic hypertrophic pachymeningitis presenting with occipital neuralgia

Recent Posts

  • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
  • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
  • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
  • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
  • Review of Leishmaniasis in the Middle East and North Africa

Recent Comments

No comments to show.

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Tags

Achives Latest News


ISSN 1680-6905

  • P. O. Box 7072 ,Kampala, Uganda
  • Call Us: 256(41)530021
  • info@africanhealthsciences.org

Latest Activities

Usefull Link

  • About AHS
  • Services
  • Focus & Scope
  • Our Articles
  • Contact Us

Subscribe

For research updates from African Health Sciences, sign up now!

[contact-form-7 id="1620" title="Subscribe"]

African Health Sciences © All Right Reserved